BRCA network joins the European Network of Gynaecological Cancer Advocacy Groups
BRCA network joins the European Network of Gynaecological Cancer Advocacy Groups
BRCA network joins the European Network of Gynaecological Cancer Advocacy Groups
On June 21st, we had the honour of participating in this important event representing BRCA+ carriers
Le 21 juin dernier, nous avons eu l’honneur de participer à cet important événement représentant les porteuses.eurs d’une …
On June 21st, we had the honour of participating in this important event representing BRCA+ carriers
Les cancers génétiques et héréditaires, leur mutations et leur impact psychologique pour le patient et ses proches
Les cancers génétiques et héréditaires, leur mutations et leur impact psychologique pour le patient et ses proches
A randomised, double blind, parallel group, placebo-controlled multicenter phase III study to assess the efficacy and safety of …
Is removal of the fallopian tubes with delayed removal of the ovaries a safe alternative for the simultaneous …
A randomised, double blind, parallel group, placebo-controlled multicenter phase III study to assess the efficacy and safety of …
BRCA+ Network asbl
N. entreprise: 1005.236.635
Cantersteen 47, 1000 Brussels, Belgium
Disclaimer: the information provided on this website should not be interpreted as medical advice. All health information should be discussed with your health care provider. Please read our full disclaimer for more information.
